{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:28:05Z","timestamp":1793276885654,"version":"4.5.0"},"reference-count":66,"publisher":"American Association for Cancer Research (AACR)","issue":"5","funder":[{"DOI":"10.13039\/100017023","name":"Paul G. Allen Frontiers Group","doi-asserted-by":"publisher","award":["12829"],"award-info":[{"award-number":["12829"]}],"id":[{"id":"10.13039\/100017023","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000015","name":"Canadian Cancer Society Research Institute","doi-asserted-by":"publisher","award":["705288"],"award-info":[{"award-number":["705288"]}],"id":[{"id":"10.13039\/501100000015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["191809"],"award-info":[{"award-number":["191809"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["148393"],"award-info":[{"award-number":["148393"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000233","name":"Genome British Columbia","doi-asserted-by":"publisher","award":["271LYM"],"award-info":[{"award-number":["271LYM"]}],"id":[{"id":"10.13039\/501100000233","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008762","name":"Genome Canada","doi-asserted-by":"publisher","award":["13124"],"award-info":[{"award-number":["13124"]}],"id":[{"id":"10.13039\/100008762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008880","name":"Kanae Foundation for the Promotion of Medical Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008880","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001219","name":"Lymphoma Research Foundation","doi-asserted-by":"publisher","award":["1176296"],"award-info":[{"award-number":["1176296"]}],"id":[{"id":"10.13039\/100001219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009812","name":"Princess Margaret Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009812","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004376","name":"Terry Fox Research Institute","doi-asserted-by":"publisher","award":["1061"],"award-info":[{"award-number":["1061"]}],"id":[{"id":"10.13039\/501100004376","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004376","name":"Terry Fox Research Institute","doi-asserted-by":"publisher","award":["1108"],"award-info":[{"award-number":["1108"]}],"id":[{"id":"10.13039\/501100004376","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008732","name":"Uehara Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008732","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>The tissue architecture of classic Hodgkin lymphoma (cHL) is unique among cancers and is characterized by rare malignant Hodgkin and Reed\u2013Sternberg cells that coevolve with a complex ecosystem of immune cells in the tumor microenvironment (TME). The lack of a comprehensive systems-level interrogation has hindered the description of disease heterogeneity and clinically relevant molecular subtypes. In this study, we employed an integrative, multimodal approach to characterize cHL tumors using malignant cell sequencing, spatial transcriptomics, and imaging mass cytometry. We identified four molecular subtypes (CST, CN913, STB, and CN2P), each characterized by distinct clinical features, mutational patterns, malignant cell gene expression profiles, and spatial architecture involving immune cell populations. Functional modeling of CSF2RB mutations, a characteristic feature of the CST subtype, revealed dysregulated oncogenic signaling and unique TME cross-talk. These findings highlight the significance of multidimensional profiling in elucidating patterns of molecular alterations that drive immune ecosystems and underlie therapeutically exploitable vulnerabilities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>Our systematic and comprehensive genomic and spatially resolved profiling of Hodgkin lymphoma revealed a paradigmatic link between a genetic disease subtype and TME composition and function. Insights into mutation-driven mechanisms of deregulated cytokine signaling will pave the way for therapeutic interventions that interfere with oncogenic signaling and cellular ecosystems in cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2159-8290.cd-25-0859","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T18:17:02Z","timestamp":1769797022000},"page":"993-1013","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Multidimensional Characterization of Tumor\u2013Immune Architecture Reveals Clinically Relevant Classic Hodgkin Lymphoma Subtypes"],"prefix":"10.1158","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6782-8361","authenticated-orcid":false,"given":"Tomohiro","family":"Aoki","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03sfybe47","id-type":"ROR","asserted-by":"publisher"}],"name":"BC Cancer 1 Centre for Lymphoid Cancer, , Vancouver, Canada."},{"id":[{"id":"https:\/\/ror.org\/03rmrcq20","id-type":"ROR","asserted-by":"publisher"}],"name":"University of British Columbia 2 Department of Pathology and Laboratory Medicine, , Vancouver, Canada."},{"id":[{"id":"https:\/\/ror.org\/03zayce58","id-type":"ROR","asserted-by":"publisher"}],"name":"Princess Margaret Cancer Centre 3 , , Toronto, Canada."},{"id":[{"id":"https:\/\/ror.org\/042xt5161","id-type":"ROR","asserted-by":"publisher"}],"name":"University Health Network 3 , , Toronto, Canada."},{"name":"4University of Toronto, Toronto, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8060-694X","authenticated-orcid":false,"given":"Gerben","family":"Duns","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03sfybe47","id-type":"ROR","asserted-by":"publisher"}],"name":"BC Cancer 1 Centre for Lymphoid Cancer, , Vancouver, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3929-9751","authenticated-orcid":false,"given":"Shinya","family":"Rai","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03sfybe47","id-type":"ROR","asserted-by":"publisher"}],"name":"BC Cancer 1 Centre for Lymphoid Cancer, , Vancouver, Canada."},{"name":"5Department of Hematology and Rheumatology, Faculty of Medicine, Kindai University, Osaka-Sayama, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6153-7595","authenticated-orcid":false,"given":"Aixiang","family":"Jiang","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03sfybe47","id-type":"ROR","asserted-by":"publisher"}],"name":"BC Cancer 1 Centre for Lymphoid Cancer, , Vancouver, Canada."},{"id":[{"id":"https:\/\/ror.org\/03rmrcq20","id-type":"ROR","asserted-by":"publisher"}],"name":"University of British Columbia 2 Department of Pathology and Laboratory Medicine, , Vancouver, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9979-3690","authenticated-orcid":false,"given":"Andrew","family":"Lytle","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03sfybe47","id-type":"ROR","asserted-by":"publisher"}],"name":"BC Cancer 1 Centre for Lymphoid Cancer, , Vancouver, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5382-478X","authenticated-orcid":false,"given":"Yifan","family":"Yin","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03sfybe47","id-type":"ROR","asserted-by":"publisher"}],"name":"BC Cancer 1 Centre for Lymphoid Cancer, , Vancouver, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3599-4643","authenticated-orcid":false,"given":"Makoto","family":"Kishida","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03sfybe47","id-type":"ROR","asserted-by":"publisher"}],"name":"BC Cancer 1 Centre for Lymphoid Cancer, , Vancouver, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5881-458X","authenticated-orcid":false,"given":"Michael","family":"Yu Li","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03sfybe47","id-type":"ROR","asserted-by":"publisher"}],"name":"BC Cancer 1 Centre for Lymphoid Cancer, , Vancouver, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0506-6661","authenticated-orcid":false,"given":"Cecilia","family":"Lee","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03sfybe47","id-type":"ROR","asserted-by":"publisher"}],"name":"BC Cancer 1 Centre for Lymphoid Cancer, , Vancouver, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6196-2479","authenticated-orcid":false,"given":"Denise","family":"Smorra","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03sfybe47","id-type":"ROR","asserted-by":"publisher"}],"name":"BC Cancer 1 Centre for Lymphoid Cancer, , Vancouver, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6413-6586","authenticated-orcid":false,"given":"Laura K.","family":"Hilton","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03sfybe47","id-type":"ROR","asserted-by":"publisher"}],"name":"BC Cancer 1 Centre for Lymphoid Cancer, , Vancouver, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5112-3784","authenticated-orcid":false,"given":"Shannon","family":"Healy","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03sfybe47","id-type":"ROR","asserted-by":"publisher"}],"name":"BC Cancer 1 Centre for Lymphoid Cancer, , Vancouver, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6825-702X","authenticated-orcid":false,"given":"Stefan K.","family":"Alig","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00f54p054","id-type":"ROR","asserted-by":"publisher"}],"name":"Stanford University 6 Department of Medicine, Divisions of Oncology and Hematology, , Stanford, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0950-3937","authenticated-orcid":false,"given":"Mohammad","family":"Shahrokh Esfahani","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00f54p054","id-type":"ROR","asserted-by":"publisher"}],"name":"Stanford University 6 Department of Medicine, Divisions of Oncology and Hematology, , Stanford, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1942-9304","authenticated-orcid":false,"given":"Clementine","family":"Sarkozy","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03sfybe47","id-type":"ROR","asserted-by":"publisher"}],"name":"BC Cancer 1 Centre for Lymphoid Cancer, , Vancouver, Canada."},{"id":[{"id":"https:\/\/ror.org\/04t0gwh46","id-type":"ROR","asserted-by":"publisher"}],"name":"Institut Curie 7 Hematology Department, , Saint Cloud, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2756-4266","authenticated-orcid":false,"given":"Stacy S.","family":"Hung","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03sfybe47","id-type":"ROR","asserted-by":"publisher"}],"name":"BC Cancer 1 Centre for Lymphoid Cancer, , Vancouver, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5616-1821","authenticated-orcid":false,"given":"Katy","family":"Milne","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03sfybe47","id-type":"ROR","asserted-by":"publisher"}],"name":"BC Cancer 8 Deeley Research Centre, , Victoria, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6901-5126","authenticated-orcid":false,"given":"Adele","family":"Telenius","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03sfybe47","id-type":"ROR","asserted-by":"publisher"}],"name":"BC Cancer 1 Centre for Lymphoid Cancer, , Vancouver, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3541-684X","authenticated-orcid":false,"given":"Luke","family":"O\u2019Brien","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03sfybe47","id-type":"ROR","asserted-by":"publisher"}],"name":"BC Cancer 1 Centre for Lymphoid Cancer, , Vancouver, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8140-6517","authenticated-orcid":false,"given":"Jasper C.H.","family":"Wong","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03sfybe47","id-type":"ROR","asserted-by":"publisher"}],"name":"BC Cancer 1 Centre for Lymphoid Cancer, , Vancouver, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1327-9639","authenticated-orcid":false,"given":"Claudia","family":"Cassidy","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03sfybe47","id-type":"ROR","asserted-by":"publisher"}],"name":"BC Cancer 1 Centre for Lymphoid Cancer, , Vancouver, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1122-6549","authenticated-orcid":false,"given":"Manabu","family":"Fujisawa","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03sfybe47","id-type":"ROR","asserted-by":"publisher"}],"name":"BC Cancer 1 Centre for Lymphoid Cancer, , Vancouver, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3374-7747","authenticated-orcid":false,"given":"Celia","family":"Strong","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03sfybe47","id-type":"ROR","asserted-by":"publisher"}],"name":"BC Cancer 8 Deeley Research Centre, , Victoria, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6399-9006","authenticated-orcid":false,"given":"Talia","family":"Goodyear","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03sfybe47","id-type":"ROR","asserted-by":"publisher"}],"name":"BC Cancer 8 Deeley Research Centre, , Victoria, Canada."},{"name":"9University of Limerick School of Medicine, Limerick, Ireland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7049-8772","authenticated-orcid":false,"given":"Chantal","family":"Di Vito","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03sfybe47","id-type":"ROR","asserted-by":"publisher"}],"name":"BC Cancer 8 Deeley Research Centre, , Victoria, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7725-710X","authenticated-orcid":false,"given":"Cassandra","family":"Luksik","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03sfybe47","id-type":"ROR","asserted-by":"publisher"}],"name":"BC Cancer 8 Deeley Research Centre, , Victoria, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5977-9713","authenticated-orcid":false,"given":"Glenn","family":"Edin","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03sfybe47","id-type":"ROR","asserted-by":"publisher"}],"name":"BC Cancer 1 Centre for Lymphoid Cancer, , Vancouver, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8158-8201","authenticated-orcid":false,"given":"Laura","family":"Gonzalez","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03sfybe47","id-type":"ROR","asserted-by":"publisher"}],"name":"BC Cancer 1 Centre for Lymphoid Cancer, , Vancouver, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6472-0715","authenticated-orcid":false,"given":"Juan","family":"Rangel Pati\u00f1o","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03zayce58","id-type":"ROR","asserted-by":"publisher"}],"name":"Princess Margaret Cancer Centre 3 , , Toronto, Canada."},{"id":[{"id":"https:\/\/ror.org\/042xt5161","id-type":"ROR","asserted-by":"publisher"}],"name":"University Health Network 3 , , Toronto, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7035-0174","authenticated-orcid":false,"given":"Michael","family":"Hong","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03zayce58","id-type":"ROR","asserted-by":"publisher"}],"name":"Princess Margaret Cancer Centre 3 , , Toronto, Canada."},{"id":[{"id":"https:\/\/ror.org\/042xt5161","id-type":"ROR","asserted-by":"publisher"}],"name":"University Health Network 3 , , Toronto, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1663-7132","authenticated-orcid":false,"given":"Shaocheng","family":"Wu","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03sfybe47","id-type":"ROR","asserted-by":"publisher"}],"name":"BC Cancer 10 Department of Molecular Oncology, , Vancouver, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2114-3118","authenticated-orcid":false,"given":"Eric","family":"Lee","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03sfybe47","id-type":"ROR","asserted-by":"publisher"}],"name":"BC Cancer 10 Department of Molecular Oncology, , Vancouver, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4610-7562","authenticated-orcid":false,"given":"Ali","family":"Sakhdari","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/042xt5161","id-type":"ROR","asserted-by":"publisher"}],"name":"University Health Network 11 Laboratory Medicine and Pathobiology Department, , Toronto, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8468-1911","authenticated-orcid":false,"given":"Katsuyoshi","family":"Takata","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03sfybe47","id-type":"ROR","asserted-by":"publisher"}],"name":"BC Cancer 1 Centre for Lymphoid Cancer, , Vancouver, Canada."},{"id":[{"id":"https:\/\/ror.org\/0445phv87","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Toyama 12 Department of Pathology, Faculty of Medicine, Academic Research Division, , Toyama, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6360-4959","authenticated-orcid":false,"given":"Tomoko","family":"Miyata-Takata","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03sfybe47","id-type":"ROR","asserted-by":"publisher"}],"name":"BC Cancer 1 Centre for Lymphoid Cancer, , Vancouver, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7618-0103","authenticated-orcid":false,"given":"Merrill","family":"Boyle","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03sfybe47","id-type":"ROR","asserted-by":"publisher"}],"name":"BC Cancer 1 Centre for Lymphoid Cancer, , Vancouver, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2867-4037","authenticated-orcid":false,"given":"Susana","family":"Ben-Neriah","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03sfybe47","id-type":"ROR","asserted-by":"publisher"}],"name":"BC Cancer 1 Centre for Lymphoid Cancer, , Vancouver, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7394-5425","authenticated-orcid":false,"given":"Andrew P.","family":"Weng","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03sfybe47","id-type":"ROR","asserted-by":"publisher"}],"name":"BC Cancer 13 Terry Fox Laboratory, , Vancouver, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4877-4358","authenticated-orcid":false,"given":"Alexander","family":"Xu","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02pammg90","id-type":"ROR","asserted-by":"publisher"}],"name":"Cedars-Sinai Medical Center 14 , Los Angeles, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7472-822X","authenticated-orcid":false,"given":"Akil","family":"Merchant","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02pammg90","id-type":"ROR","asserted-by":"publisher"}],"name":"Cedars-Sinai Medical Center 14 , Los Angeles, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3422-8823","authenticated-orcid":false,"given":"Andrew","family":"Roth","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03sfybe47","id-type":"ROR","asserted-by":"publisher"}],"name":"BC Cancer 10 Department of Molecular Oncology, , Vancouver, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2230-8538","authenticated-orcid":false,"given":"Michael","family":"Crump","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03zayce58","id-type":"ROR","asserted-by":"publisher"}],"name":"Princess Margaret Cancer Centre 3 , , Toronto, Canada."},{"id":[{"id":"https:\/\/ror.org\/042xt5161","id-type":"ROR","asserted-by":"publisher"}],"name":"University Health Network 3 , , Toronto, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6117-320X","authenticated-orcid":false,"given":"John","family":"Kuruvilla","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03zayce58","id-type":"ROR","asserted-by":"publisher"}],"name":"Princess Margaret Cancer Centre 3 , , Toronto, Canada."},{"id":[{"id":"https:\/\/ror.org\/042xt5161","id-type":"ROR","asserted-by":"publisher"}],"name":"University Health Network 3 , , Toronto, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5621-9261","authenticated-orcid":false,"given":"Anca","family":"Prica","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03zayce58","id-type":"ROR","asserted-by":"publisher"}],"name":"Princess Margaret Cancer Centre 3 , , Toronto, Canada."},{"id":[{"id":"https:\/\/ror.org\/042xt5161","id-type":"ROR","asserted-by":"publisher"}],"name":"University Health Network 3 , , Toronto, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0287-7124","authenticated-orcid":false,"given":"Robert","family":"Kridel","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03zayce58","id-type":"ROR","asserted-by":"publisher"}],"name":"Princess Margaret Cancer Centre 3 , , Toronto, Canada."},{"id":[{"id":"https:\/\/ror.org\/042xt5161","id-type":"ROR","asserted-by":"publisher"}],"name":"University Health Network 3 , , Toronto, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4934-3322","authenticated-orcid":false,"given":"David G.","family":"Huntsman","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03rmrcq20","id-type":"ROR","asserted-by":"publisher"}],"name":"University of British Columbia 2 Department of Pathology and Laboratory Medicine, , Vancouver, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4445-5539","authenticated-orcid":false,"given":"Brad H.","family":"Nelson","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03sfybe47","id-type":"ROR","asserted-by":"publisher"}],"name":"BC Cancer 8 Deeley Research Centre, , Victoria, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9364-9391","authenticated-orcid":false,"given":"Pedro","family":"Farinha","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03sfybe47","id-type":"ROR","asserted-by":"publisher"}],"name":"BC Cancer 1 Centre for Lymphoid Cancer, , Vancouver, Canada."},{"id":[{"id":"https:\/\/ror.org\/03rmrcq20","id-type":"ROR","asserted-by":"publisher"}],"name":"University of British Columbia 2 Department of Pathology and Laboratory Medicine, , Vancouver, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2932-7800","authenticated-orcid":false,"given":"Ryan D.","family":"Morin","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03sfybe47","id-type":"ROR","asserted-by":"publisher"}],"name":"BC Cancer 1 Centre for Lymphoid Cancer, , Vancouver, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5153-5625","authenticated-orcid":false,"given":"Ash A.","family":"Alizadeh","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00f54p054","id-type":"ROR","asserted-by":"publisher"}],"name":"Stanford University 6 Department of Medicine, Divisions of Oncology and Hematology, , Stanford, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5835-9863","authenticated-orcid":false,"given":"Kerry J.","family":"Savage","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03sfybe47","id-type":"ROR","asserted-by":"publisher"}],"name":"BC Cancer 1 Centre for Lymphoid Cancer, , Vancouver, Canada."},{"id":[{"id":"https:\/\/ror.org\/03rmrcq20","id-type":"ROR","asserted-by":"publisher"}],"name":"University of British Columbia 15 Department of Medicine, , Vancouver, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0435-5947","authenticated-orcid":false,"given":"David W.","family":"Scott","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03sfybe47","id-type":"ROR","asserted-by":"publisher"}],"name":"BC Cancer 1 Centre for Lymphoid Cancer, , Vancouver, Canada."},{"id":[{"id":"https:\/\/ror.org\/03rmrcq20","id-type":"ROR","asserted-by":"publisher"}],"name":"University of British Columbia 15 Department of Medicine, , Vancouver, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9842-9750","authenticated-orcid":false,"given":"Christian","family":"Steidl","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03sfybe47","id-type":"ROR","asserted-by":"publisher"}],"name":"BC Cancer 1 Centre for Lymphoid Cancer, , Vancouver, Canada."},{"id":[{"id":"https:\/\/ror.org\/03rmrcq20","id-type":"ROR","asserted-by":"publisher"}],"name":"University of British Columbia 2 Department of Pathology and Laboratory Medicine, , Vancouver, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"key":"2026052113563980500_bib1","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes","volume":"24","author":"Chapuy","year":"2018","journal-title":"Nat Med"},{"key":"2026052113563980500_bib2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41586-022-05068-3","article-title":"Genomics to select treatment for patients with metastatic breast cancer","volume":"610","author":"Andre","year":"2022","journal-title":"Nature"},{"key":"2026052113563980500_bib3","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/s41588-022-01100-4","article-title":"Single-cell and bulk transcriptome sequencing identifies two epithelial tumor cell states and refines the consensus molecular classification of colorectal cancer","volume":"54","author":"Joanito","year":"2022","journal-title":"Nat Genet"},{"key":"2026052113563980500_bib4","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1056\/NEJMoa0909530","article-title":"Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR","volume":"362","author":"Maemondo","year":"2010","journal-title":"N Engl J Med"},{"key":"2026052113563980500_bib5","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1126\/science.1099314","article-title":"EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy","volume":"304","author":"Paez","year":"2004","journal-title":"Science"},{"key":"2026052113563980500_bib6","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1200\/JCO.20.01761","article-title":"Biology in practice: harnessing the curative potential of the immune system in lymphoid cancers","volume":"39","author":"Aoki","year":"2021","journal-title":"J Clin Oncol"},{"key":"2026052113563980500_bib7","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1182\/blood-2010-05-282780","article-title":"Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma","volume":"116","author":"Green","year":"2010","journal-title":"Blood"},{"key":"2026052113563980500_bib8","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nature09754","article-title":"MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers","volume":"471","author":"Steidl","year":"2011","journal-title":"Nature"},{"key":"2026052113563980500_bib9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1056\/NEJMoa1804980","article-title":"Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma","volume":"380","author":"Schuster","year":"2019","journal-title":"N Engl J Med"},{"key":"2026052113563980500_bib10","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa1708566","article-title":"Chimeric antigen receptor T cells in refractory B-cell lymphomas","volume":"377","author":"Schuster","year":"2017","journal-title":"N Engl J Med"},{"key":"2026052113563980500_bib11","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1056\/NEJMoa1707447","article-title":"Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma","volume":"377","author":"Neelapu","year":"2017","journal-title":"N Engl J Med"},{"key":"2026052113563980500_bib12","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1182\/blood.V128.22.1107.1107","article-title":"Pembrolizumab in relapsed\/refractory classical Hodgkin lymphoma: primary end point analysis of the phase 2 keynote-087 study","volume":"128","author":"Moskowitz","year":"2016","journal-title":"Blood"},{"key":"2026052113563980500_bib13","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1182\/blood.V128.22.1110.1110","article-title":"Checkmate 205 update with minimum 12-month follow up: a phase 2 study of nivolumab in patients with relapsed\/refractory classical Hodgkin lymphoma","volume":"128","author":"Timmerman","year":"2016","journal-title":"Blood"},{"key":"2026052113563980500_bib14","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S1470-2045(16)30167-X","article-title":"Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial","volume":"17","author":"Younes","year":"2016","journal-title":"Lancet Oncol"},{"key":"2026052113563980500_bib15","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1200\/JCO.2016.72.1316","article-title":"Phase II study of the efficacy and safety of pembrolizumab for relapsed\/refractory classic Hodgkin lymphoma","volume":"35","author":"Chen","year":"2017","journal-title":"J Clin Oncol"},{"key":"2026052113563980500_bib16","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1200\/JCO.2017.76.0793","article-title":"Nivolumab for relapsed\/refractory classic Hodgkin lymphoma after failure of autologous hematopoietic cell transplantation: extended follow-up of the multicohort single-arm phase II CheckMate 205 trial","volume":"36","author":"Armand","year":"2018","journal-title":"J Clin Oncol"},{"key":"2026052113563980500_bib17","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1182\/blood-2014-07-537480","article-title":"Risk assessment in the management of newly diagnosed classical Hodgkin lymphoma","volume":"125","author":"Connors","year":"2015","journal-title":"Blood"},{"key":"2026052113563980500_bib18","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"2026052113563980500_bib19","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1182\/blood.2022017147","article-title":"Novel insights into Hodgkin lymphoma biology by single-cell analysis","volume":"141","author":"Aoki","year":"2023","journal-title":"Blood"},{"key":"2026052113563980500_bib20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41572-020-0189-6","article-title":"Hodgkin lymphoma","volume":"6","author":"Connors","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"2026052113563980500_bib21","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1158\/2159-8290.CD-19-0680","article-title":"Single-cell transcriptome analysis reveals disease-defining T-cell subsets in the tumor microenvironment of classic Hodgkin lymphoma","volume":"10","author":"Aoki","year":"2020","journal-title":"Cancer Discov"},{"key":"2026052113563980500_bib22","doi-asserted-by":"crossref","first-page":"e2105822118","DOI":"10.1073\/pnas.2105822118","article-title":"Single-cell profiling reveals the importance of CXCL13\/CXCR5 axis biology in lymphocyte-rich classic Hodgkin lymphoma","volume":"118","author":"Aoki","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026052113563980500_bib23","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1182\/blood-2014-11-610436","article-title":"Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells","volume":"125","author":"Reichel","year":"2015","journal-title":"Blood"},{"key":"2026052113563980500_bib24","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2017-11-814913","article-title":"Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma","volume":"131","author":"Tiacci","year":"2018","journal-title":"Blood"},{"key":"2026052113563980500_bib25","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1182\/blood-2017-11-812073","article-title":"Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma","volume":"131","author":"Spina","year":"2018","journal-title":"Blood"},{"key":"2026052113563980500_bib26","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1200\/JCO.23.01867","article-title":"Circulating tumor DNA sequencing for biologic classification and individualized risk stratification in patients with Hodgkin lymphoma","volume":"42","author":"Heger","year":"2024","journal-title":"J Clin Oncol"},{"key":"2026052113563980500_bib27","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/s41586-023-06903-x","article-title":"Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling","volume":"625","author":"Alig","year":"2024","journal-title":"Nature"},{"key":"2026052113563980500_bib28","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1182\/blood-2012-06-439570","article-title":"Gene expression profiling of microdissected Hodgkin Reed-Sternberg cells correlates with treatment outcome in classical Hodgkin lymphoma","volume":"120","author":"Steidl","year":"2012","journal-title":"Blood"},{"key":"2026052113563980500_bib29","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1182\/blood-2009-12-257345","article-title":"Genome-wide copy number analysis of Hodgkin Reed-Sternberg cells identifies recurrent imbalances with correlations to treatment outcome","volume":"116","author":"Steidl","year":"2010","journal-title":"Blood"},{"key":"2026052113563980500_bib30","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/MOH.0000000000000155","article-title":"Genomic alterations underlying immune privilege in malignant lymphomas","volume":"22","author":"Mottok","year":"2015","journal-title":"Curr Opin Hematol"},{"key":"2026052113563980500_bib31","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1182\/bloodadvances.2019001012","article-title":"Genomic analyses of flow-sorted Hodgkin Reed-Sternberg cells reveal complementary mechanisms of immune evasion","volume":"3","author":"Wienand","year":"2019","journal-title":"Blood Adv"},{"key":"2026052113563980500_bib32","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1158\/2643-3230.BCD-22-0128","article-title":"Molecular evolution of classic Hodgkin lymphoma revealed through whole-genome sequencing of Hodgkin and reed sternberg cells","volume":"4","author":"Maura","year":"2023","journal-title":"Blood Cancer Discov"},{"key":"2026052113563980500_bib33","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1200\/JCO.23.01115","article-title":"Spatially resolved tumor microenvironment predicts treatment outcomes in relapsed\/refractory Hodgkin lymphoma","volume":"42","author":"Aoki","year":"2024","journal-title":"J Clin Oncol"},{"key":"2026052113563980500_bib34","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1182\/blood.2020007507","article-title":"Mutational landscape of gray zone lymphoma","volume":"137","author":"Sarkozy","year":"2021","journal-title":"Blood"},{"key":"2026052113563980500_bib35","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrc3774","article-title":"The tumour microenvironment in B cell lymphomas","volume":"14","author":"Scott","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"2026052113563980500_bib36","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1158\/2159-8290.CD-18-1090","article-title":"Molecular and genetic characterization of MHC deficiency identifies EZH2 as therapeutic target for enhancing immune recognition","volume":"9","author":"Ennishi","year":"2019","journal-title":"Cancer Discov"},{"key":"2026052113563980500_bib37","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1158\/2326-6066.CIR-16-0201","article-title":"Classical Hodgkin lymphoma with reduced beta2M\/MHC class I expression is associated with inferior outcome independent of 9p24.1 status","volume":"4","author":"Roemer","year":"2016","journal-title":"Cancer Immunol Res"},{"key":"2026052113563980500_bib38","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/08830180902978120","article-title":"Molecular mechanisms of IFN-gamma to up-regulate MHC class I antigen processing and presentation","volume":"28","author":"Zhou","year":"2009","journal-title":"Int Rev Immunol"},{"key":"2026052113563980500_bib39","doi-asserted-by":"crossref","first-page":"4164","DOI":"10.1073\/pnas.0308531101","article-title":"Metagenes and molecular pattern discovery using matrix factorization","volume":"101","author":"Brunet","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026052113563980500_bib40","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","article-title":"Inference and analysis of cell-cell communication using CellChat","volume":"12","author":"Jin","year":"2021","journal-title":"Nat Commun"},{"key":"2026052113563980500_bib41","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1182\/blood-2007-05-085159","article-title":"PD-1-PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma","volume":"111","author":"Yamamoto","year":"2008","journal-title":"Blood"},{"key":"2026052113563980500_bib42","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.immuni.2019.03.022","article-title":"GM-CSF, IL-3, and IL-5 family of cytokines: regulators of inflammation","volume":"50","author":"Dougan","year":"2019","journal-title":"Immunity"},{"key":"2026052113563980500_bib43","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large B-cell lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N Engl J Med"},{"key":"2026052113563980500_bib44","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cell.2017.09.027","article-title":"Genetic and functional drivers of diffuse large B cell lymphoma","volume":"171","author":"Reddy","year":"2017","journal-title":"Cell"},{"key":"2026052113563980500_bib45","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S1470-2045(15)00169-2","article-title":"Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry","volume":"16","author":"Pastore","year":"2015","journal-title":"Lancet Oncol"},{"key":"2026052113563980500_bib46","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1517\/13543784.2013.775244","article-title":"Targeting the JAK-STAT pathway in lymphoma: a focus on pacritinib","volume":"22","author":"Derenzini","year":"2013","journal-title":"Expert Opin Investig Drugs"},{"key":"2026052113563980500_bib47","doi-asserted-by":"crossref","first-page":"17945","DOI":"10.1073\/pnas.1316796110","article-title":"Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans","volume":"110","author":"Sugiyama","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026052113563980500_bib48","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/s41375-021-01204-6","article-title":"Molecular biology of Hodgkin lymphoma","volume":"35","author":"Weniger","year":"2021","journal-title":"Leukemia"},{"key":"2026052113563980500_bib49","doi-asserted-by":"crossref","first-page":"840","DOI":"10.3324\/haematol.2017.180554","article-title":"A phase II study of the oral JAK1\/JAK2 inhibitor ruxolitinib in advanced relapsed\/refractory Hodgkin lymphoma","volume":"103","author":"Van Den Neste","year":"2018","journal-title":"Haematologica"},{"key":"2026052113563980500_bib50","doi-asserted-by":"crossref","first-page":"eade8520","DOI":"10.1126\/science.ade8520","article-title":"JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma","volume":"384","author":"Zak","year":"2024","journal-title":"Science"},{"key":"2026052113563980500_bib51","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1056\/NEJMoa2405888","article-title":"Nivolumab+AVD in advanced-stage classic Hodgkin\u2019s lymphoma","volume":"391","author":"Herrera","year":"2024","journal-title":"N Engl J Med"},{"key":"2026052113563980500_bib52","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1056\/NEJMoa2206125","article-title":"Overall survival with brentuximab vedotin in stage III or IV Hodgkin\u2019s lymphoma","volume":"387","author":"Ansell","year":"2022","journal-title":"N Engl J Med"},{"key":"2026052113563980500_bib53","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1056\/NEJMoa2206660","article-title":"Brentuximab vedotin with chemotherapy in pediatric high-risk Hodgkin\u2019s lymphoma","volume":"387","author":"Castellino","year":"2022","journal-title":"N Engl J Med"},{"key":"2026052113563980500_bib54","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1200\/JCO.2017.72.7925","article-title":"Prognostic model to predict post-autologous stem-cell transplantation outcomes in classical Hodgkin lymphoma","volume":"35","author":"Chan","year":"2017","journal-title":"J Clin Oncol"},{"key":"2026052113563980500_bib55","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/bioinformatics\/btp373","article-title":"VarScan: variant detection in massively parallel sequencing of individual and pooled samples","volume":"25","author":"Koboldt","year":"2009","journal-title":"Bioinformatics"},{"key":"2026052113563980500_bib56","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1093\/bioinformatics\/bts271","article-title":"Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs","volume":"28","author":"Saunders","year":"2012","journal-title":"Bioinformatics"},{"key":"2026052113563980500_bib57","doi-asserted-by":"crossref","first-page":"e1004873","DOI":"10.1371\/journal.pcbi.1004873","article-title":"CNVkit: genome-wide copy number detection and visualization from targeted DNA sequencing","volume":"12","author":"Talevich","year":"2016","journal-title":"PLoS Comput Biol"},{"key":"2026052113563980500_bib58","doi-asserted-by":"crossref","first-page":"R41","DOI":"10.1186\/gb-2011-12-4-r41","article-title":"GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers","volume":"12","author":"Mermel","year":"2011","journal-title":"Genome Biol"},{"key":"2026052113563980500_bib59","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ccell.2024.01.010","article-title":"Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade","volume":"42","author":"Nabet","year":"2024","journal-title":"Cancer Cell"},{"key":"2026052113563980500_bib60","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/s41592-019-0582-9","article-title":"ilastik: interactive machine learning for (bio)image analysis","volume":"16","author":"Berg","year":"2019","journal-title":"Nat Methods"},{"key":"2026052113563980500_bib61","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41586-019-1876-x","article-title":"The single-cell pathology landscape of breast cancer","volume":"578","author":"Jackson","year":"2020","journal-title":"Nature"},{"key":"2026052113563980500_bib62","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1182\/blood-2017-09-808907","article-title":"Somatic IL4R mutations in primary mediastinal large B-cell lymphoma lead to constitutive JAK-STAT signaling activation","volume":"131","author":"Vigan\u00f2","year":"2018","journal-title":"Blood"},{"key":"2026052113563980500_bib63","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"2026052113563980500_bib64","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"key":"2026052113563980500_bib65","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"2026052113563980500_bib66","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"}],"container-title":["Cancer Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article-pdf\/doi\/10.1158\/2159-8290.CD-25-0859\/3731997\/cd-25-0859.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article-pdf\/doi\/10.1158\/2159-8290.CD-25-0859\/3755561\/cd-25-0859.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article-pdf\/16\/5\/993\/3785920\/cd-25-0859.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article-pdf\/16\/5\/993\/3785920\/cd-25-0859.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T17:56:54Z","timestamp":1779386214000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article\/16\/5\/993\/784409\/Multidimensional-Characterization-of-Tumor-Immune"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":66,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,1,30]]},"published-print":{"date-parts":[[2026,5,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2159-8290.cd-25-0859","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2159-8290.32697659","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.32702097","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.32702094","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.32697662","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2159-8290.c.8541917","asserted-by":"object"}]},"ISSN":["2159-8274","2159-8290"],"issn-type":[{"value":"2159-8274","type":"print"},{"value":"2159-8290","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]}}}